STB
JAZZ icon

S&T Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

S&T Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34K Buy
+18
New +$3.94K ﹤0.01% 349

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

S&T Bank's JAZZ Position: Q2 2026 in Review

S&T Bank opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 18 shares worth $4.34K. The stake represents ﹤0.01% of the portfolio and ranks #349 among its holdings.

642 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • S&T Bank held 18 shares of Jazz Pharmaceuticals worth $4.34K as of Q2 2026.
  • Jazz Pharmaceuticals was a new S&T Bank position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of S&T Bank's portfolio in Q2 2026, its #349 holding.
  • 642 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.